Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia

• Published in: Proceedings of the National Academy of Sciences - PNAS 2009-01, Vol.106 (4), p.1187-1192
• Main Authors: Calado, Rodrigo T, Regal, Joshua A, Hills, Mark, Yewdell, William T, Dalmazzo, Leandro F, Zago, Marco A, Lansdorp, Peter M, Hogge, Donna, Chanock, Stephen J, Estey, Elihu H, Falcão, Roberto P, Young, Neal S
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Apoptosis; Biological Sciences; Blood; Bone marrow; Case-Control Studies; Cell Line; Child; Child, Preschool; Codons; Disease remission; DNA; Enzyme kinetics; Female; Gene expression; Genetic mutation; Humans; Leukemia; Leukemia, Myeloid, Acute - enzymology; Leukemia, Myeloid, Acute - genetics; Male; Middle Aged; Molecular Sequence Data; Mutation; Mutation - genetics; Myeloid leukemia; Stem cells; Telomerase - chemistry; Telomerase - genetics; Telomere - metabolism; Telomeres
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.0807057106

Loss-of-function mutations in telomerase complex genes can cause bone marrow failure, dyskeratosis congenita, and acquired aplastic anemia, both diseases that predispose to acute myeloid leukemia. Loss of telomerase function produces short telomeres, potentially resulting in chromosome recombination, end-to-end fusion, and recognition as damaged DNA. We investigated whether mutations in telomerase genes also occur in acute myeloid leukemia. We screened bone marrow samples from 133 consecutive patients with acute myeloid leukemia and 198 controls for variations in TERT and TERC genes. An additional 89 patients from a second cohort, selected based on cytogenetic status, and 528 controls were further examined for mutations. A third cohort of 372 patients and 384 controls were specifically tested for one TERT gene variant. In the first cohort, 11 patients carried missense TERT gene variants that were not present in controls (P < 0.0001); in the second cohort, TERT mutations were associated with trisomy 8 and inversion 16. Mutation germ-line origin was demonstrated in 5 patients from whom other tissues were available. Analysis of all 3 cohorts (n = 594) for the most common gene variant (A1062T) indicated a prevalence 3 times higher in patients than in controls (n = 1,110; P = 0.0009). Introduction of TERT mutants into telomerase-deficient cells resulted in loss of enzymatic activity by haploinsufficiency. Inherited mutations in TERT that reduce telomerase activity are risk factors for acute myeloid leukemia. We propose that short and dysfunctional telomeres limit normal stem cell proliferation and predispose for leukemia by selection of stem cells with defective DNA damage responses that are prone to genome instability.